Hongjie Deng

Phase I, Pharmacokinetic, and Pharmacodynamic Study of AMG 479, a Fully Human Monoclonal Antibody to Insulin-Like Growth Factor Receptor 1

Anthony W. Tolcher, John Sarantopoulos, Amita Patnaik et al. · Journal of Clinical Oncology · 2009 · 307 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Phase II Study of Ganitumab, a Fully Human Anti–Type-1 Insulin-Like Growth Factor Receptor Antibody, in Patients With Metastatic Ewing Family Tumors or Desmoplastic Small Round Cell Tumors

William D. Tap, George D. Demetri, Phillip Barnette et al. · Journal of Clinical Oncology · 2012 · 219 citations

Pharmacy, Pharmacokinetics, Pharmacotherapy +17

Safety, Pharmacokinetics, and Pharmacodynamics of AMG 102, a Fully Human Hepatocyte Growth Factor–Neutralizing Monoclonal Antibody, in a First-in-Human Study of Patients with Advanced Solid Tumors

Michael S. Gordon, Christopher J. Sweeney, David S. Mendelson et al. · Clinical Cancer Research · 2010 · 161 citations · Full text

Pharmacy, Oncology, Pharmacology +17

A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation

Myles Wolf, Matthew R. Weir, Nelson Kopyt et al. · Transplantation · 2015 · 150 citations · Full text

Medicine, Endocrinology, Nephrology +17

Randomized Phase Ib/II Trial of Rilotumumab or Ganitumab with Panitumumab versus Panitumumab Alone in Patients with Wild-type <i>KRAS</i> Metastatic Colorectal Cancer

Eric Van Cutsem, Cathy Eng, Elżbieta Nowara et al. · Clinical Cancer Research · 2014 · 109 citations · Full text

Medicine, Oncology, Pharmacology +15